RNS Number : 2974A
Arden Partners plc
31 July 2008
 



For Immediate Release

31 July 2008



Arden Partners plc

("Arden" or the "Group")


Interim results for the six months ended 30 April 2008



Arden Partners plc (AIM: ARDN.L), the institutional stockbroking company, today announces its unaudited interim results for the six month period ended 30 April 2008.


Highlights












(* underlying profits are profits before share based payments of £275k (2007:£17k) and exceptional costs of £nil (2007: £318k)





Arden Partners plc

0207 398 1630

Jonathan Keeling - Chief Executive Officer


Trevor Norris - Group Finance Director




Altium - NOMAD to Arden Partners plc

0207 484 4040

Phil Adams 


Sam Fuller




Buchanan Communications

0207 466 5000

Mark Edwards





CHIEF EXECUTIVE'S STATEMENT

For the six months ended 30 April 2008


Markets remain challenging however the interim results are in line with the Board'overall expectations.


Income from the Equities Division was ahead of the comparative period by 17%.

 

Corporate Finance Division income was down more than indicated at the AGM primarily because of the Indus IPO being moved into the second half.


Arden has continued to invest in staff in line with its growth strategy.


Earlier this year the Group was subject to an aborted bid approach from Cenkos Securities plc.  Subsequently, on 16th May the Board said that it had received preliminary approaches from a number of parties which may or may not lead to an offer being made for the Group These discussions continue.


Given the delivery of corporate income since the first half together with a reasonably good pipeline, the Board has decided to maintain the interim dividend at 2.2p per ordinary share.


Results and dividend


The results for the period reflect the first time adoption of International Financial Reporting Standards ("IFRS"). During the six months ended 30 April 2008, revenue was down by 20% to £6.7m (2007: £8.4m) and underlying profit before tax (before share based payments of £275k (2007: £17k) and exceptional costs of £Nil (2007: £318k)) fell by 46% to £1.6m (2007: £3.0m). Underlying basic earnings per share (before share based payments and exceptional costs) were 4.4p (2007: 8.8p).


Net assets have increased to £10.4m including cash balances of £8.2m.


The Board has declared a maintained interim dividend of 2.2p (2007: 2.2p). The dividend will be payable on 3 October 2008 to all shareholders on the register at 12 September 2008.


Equities Division


Income from research, sales and trading has continued to grow with revenue increasing by 17% from £3.5m to £4.1m.  We have further strengthened our sales, research and market making teams and we continue to pursue high quality individuals. 


Corporate Finance Division


The Corporate Finance ("CF") division's income was down in the period reflecting more difficult market conditions and the move of the Indus IPO into the second half. However, the CF division's income has some resilient characteristics due to the Group's exposure to the oil & gas sector and India's growth.


During the period CF income was characterised by fees derived mainly from M&A activity. Since the interim period end, we have successfully listed Indus Gas on AIM raising $50 million on a market capitalisation of $550 million and Arden has assisted with the IPO of KSK's Indian subsidiary, KSK Energy Ventures on the Bombay and National Stock Exchanges. We have also acted as Rule 3 advisers in the takeover of Virotec. 


We are currently working on a range of domestic and Indian focussed opportunities, including M&A, secondary placings and also for later in the year, selective IPOs dependent on market conditions and developments.


Staff


The whole team contributes greatly to the success of the business and we are grateful for their hard work ethic.  We will continue to reward our staff on a performance basis focused strongly on delivering shareholder value.


Outlook


Whilst UK small mid-cap markets remain challenging, the second half has started well. With a pipeline including internationally focused business, the Board anticipates a satisfactory second half to the financial year.



Jonathan Keeling

Chief Executive

31 July 2008



CONSOLIDATED INCOME STATEMENT

For the six months ended 30 April 2008





Six months

ended

30 April 2008

Unaudited



Six months

ended

30 April 2007

Unaudited 



Year 

ended

31 October 2007

Unaudited



Note

£'000

£'000

£'000






Revenue

2

6,657

8,448

16,819

Administrative expenses 

3

5,591

5,951

12,071

Profit from operations


1,066

2,497

4,748

Finance income 


271

184

461

Finance costs


-

6

3

Profit before taxation


1,337

2,675

5,206

Income tax expense


518

857

1,717

Profit on ordinary activities after taxation


819

1,818

3,489





    

Earnings per share





Basic

4

3.3p

7.4p

14.1p

Diluted

4

3.2p

7.1p

13.1p




    

CONSOLIDATED BALANCE SHEET

At 30 April 2008

 

 
 
 
At
30 April 2008
Unaudited
At
30 April 2007
Unaudited
At
31 October 2007 unaudited
 
 
£’000
£’000
£’000
Assets
 
 
 
 
Non-current assets
 
 
 
 
Plant property and equipment
 
439
443
512
Deferred Tax
 
-
5
-
Total non-current assets
 
439
448
512
 
 
 
 
 
Current assets
 
 
 
 
Financial assets – held for trading
 
880
2,806
1,652
Financial assets- available for sale
 
20
822
443
Pledged assets
 
-
882
-
Trade and other receivables
 
8,904
13,155
9,753
Cash and cash equivalents
 
8,151
5,289
7,855
Total current assets
 
17,955
22,954
19,703
Total assets
 
18,394
23,402
20,215
Current liabilities
 
 
 
 
Trade and other payables
 
7,532
13,401
8,992
Corporation tax liability
 
495
851
806
Total current liabilities
 
8,027
14,252
9,798
Non current liabilities
 
 
 
 
Deferred tax liability
 
-
-
28
Total non-current liabilities
 
-
-
28
Total liabilities
 
8,027
14,252
9,826
 
 
 
 
 
Net assets
 
10,367
9,150
10,389

            

Financed by:
 
 
 
 
Called up share capital
 
2,470
2,470
2,470
Share premium account
 
2,646
2,646
2,646
Employee Benefit Trust Reserve
 
(200)
(200)
(200)
Profit and loss account
 
5,451
4,256
5,438
Available for sale reserve
 
-
(22)
35
Total equity
 
10,367
9,150
10,389


 





CONSOLIDATED CASH FLOW STATEMENT

For the period ended 30 April 2008



Six months

ended

30 April 2008

Unaudited

Six months

ended

30 April 2007

Unaudited

Year ended

31 October 2007

Unaudited


£'000

£'000

£'000

Operating activities before taxation




Net profit from ordinary activities before tax

1,337

2,675

5,206

Adjustments for:




Fair value adjustments on held for trading assets

(35)

14

45

Depreciation

141

101

236

Interest expense/(receivable)

(271)

(178)

(458)

Share based payments

275

17

34





Operating profit before changes in working capital

1,447

2,629

5,063





Decrease/(Increase) in trade and other receivables

817

(6,906)

(2,629)

Sale/(Purchase) of financial assets 

1,530

(1,869)

(254)

Increase/(Decrease) in trade and other payables

(1,795)

4,295

(159)





Cash generated from operations

1,999

(1,851)

2,021





Income taxes paid

(806)

(676)

(1,575)





Cash flows from operating activities

1,193

(2,527)

446





Investing activities




Purchases of fixed assets

(68)

(156)

(360)

Interest received

252

157

458


184

1

98





Financing activities




Dividends paid to equity shareholders

(1,081)

(445)

(949)





Increase/(decrease) in cash and cash equivalents

296

(2,971)

(405)





Cash and cash equivalents at the beginning of the period

7,855

8,260

8,260





Cash and cash equivalents at the end of the period

8,151

5,289

7,855


 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the period ended 30 April 2008

Unaudited Statement of changes in equity for the six months ended 30 April 2008



Share

Capital

Share

Premium

Account

Employee

Benefit Trust

Reserve

Available

for sale

reserve

Retained

earnings

Total


£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 October 2007

2,470

2,646

(200)

35

5,438

10,389

Available for sale investments:







   Valuation gains/(losses) taken to equity

-

-

-

(51)

-

(51)

  Tax taken to equity

-

-

-

16

-

16

Profit for the period

-

-

-

-

819

819

Dividends

-

-

-

-

(1,081)

(1,081)

Share based payment

-

-

-

-

275

275

Balance at 30 April 2008

2,470

2,646

(200)

-

5,451

10,367



Unaudited Statement of changes in equity for the six months ended 30 April 2007



Share

Capital

Share

Premium

Account

Employee

Benefit Trust

Reserve

Available

for sale

reserve

Retained

earnings

Total


£'000

£'000

£'000

£'000

£'000

£'000

Balance at 31 October 2006

2,470

2,646

(200)

(107)

2,866

7,675

Available for sale investments:







   Valuation gains/(losses) taken to equity

-

-

-

121

-

121

  Tax taken to equity

-

-

-

(36)

-

(36)

Profit for the period

-

-

-

-

1,818

1,818

Dividends

-

-

-

-

(445)

(445)

Share based payment

-

-

-

-

17

17

Balance at 30 April 2007

2,470

2,646

(200)

(22)

4,256

9,150


Notes to the condensed Financial Statements


 1)         Basis of preparation


The financial information for the six months ended 30 April 2008 and for the six months ended 30 April 2007 is unaudited.  The financial information presented for the Group does not constitute "statutory accounts" within the meaning of Section 240 of the Companies Act 1985.


The information for the year ended 31 October 2007 has been extracted from the financial statements of the statutory accounts of Arden Partners plc which were prepared under UK Generally Accepted Accounting Principles ("UK GAAP") and have been delivered to the Registrar of Companies. The auditors have reported on those financial statements; their report was unqualified, did not include any references to which the auditors drew attention by way of emphasis without qualifying their report and did not contain any statements under either Section 237(2) or Section 237(3) of the Companies Act 1985. This audited information has been restated, as necessary, for the adoption of IFRS. The restatements have not been audited.



      Accounting policies


The condensed consolidated financial information for the six months ended 30 April 2008 has been prepared in accordance with the Disclosure of Transparency Rules of the Financial Services Authority and with IAS 34, 'Interim Financial Reporting' as adopted by the European Union.


The financial information presented in this report has been prepared using accounting policies that will be used in the preparation of the financial statements for the year ending 31 October 2008. 


These policies are in accordance with International Financial Reporting Standards, International Accounting Standards and Interpretations (collectively IFRS) issued by the International Accounting Standards Board as endorsed for use in the European Union, that are expected to be applicable for the year ending 31 October 2008. 


The significant accounting policies in relation to the IFRS adoption are as follows:



Revenue


Revenue comprises the net trading gains or losses of shares traded on a principal basis, commissions and fees earned from trading shares on an agency basis, together with fees derived from corporate finance activities, broking services and retainers.


Revenue is recognised at the fair value of the consideration receivable, to the extent that it is probable that the economic benefits associated with the transaction will flow to the Group.  Where consideration includes financial instruments or other nonߛcash items, revenue is measured at fair value using an appropriate valuation method. 


The 
Group recognises revenue at the point of completing an assignment to the extent that it has obtained the right to consideration through performance of its services to clients.


Deal fees and placing commissions are only recognised once there is an absolute contractual entitlement for the Group to receive them.


Institutional Commissions are recognised on trade dates. Net trading gains or losses are the realised and unrealised profits and losses from market making long and short positions on a trade date basis.


Corporate retainers are recognised on an accruals basis.



              Financial assets


The Group classifies its financial assets into one of the categories discussed below, depending on the purpose for which the asset was acquired. The Group has not classified any of its financial assets as held to maturity.


The Group's accounting policy for each category is as follows:


Held for trading:  Trading investments and their associated financial liabilities represent market making positions and other investments held for resale in the near term and are stated at fair value.  Gains and losses from the changes in fair value are taken to the income statement.


For trading investments which are quoted in active markets, fair values are determined by reference to the current quoted bid price.  Where independent prices are not available, fair value is determined using valuation techniques with reference to observable market data.  These may include comparison to similar instruments where observable prices exist, discounted cash flow analysis and other valuation techniques that are commonly used by market participants.


Loans and receivables:  These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services to customers (e.g. trade receivables), but also incorporate other types of contractual monetary asset. They are initially recognised at fair value plus transaction costs that are directly attributable to their acquisition or issue, and are subsequently carried at amortised cost using the effective interest rate method, less provision for impairment. 


Impairment provisions are recognised when there is objective evidence (such as significant financial difficulties on the part of the counterparty or default or significant delay in payment) that the Group will be unable to collect all of the amounts due under the terms receivable, the amount of such a provision being the difference between the net carrying amount and the present value of the future expected cash flows associated with the impaired receivable. For trade receivables, which are reported net, such provisions are recorded in a separate allowance account with the loss being recognised within administrative expenses in the income statement. On confirmation that the trade receivable will not be collectable, the gross carrying value of the asset is written off against the associated provision.

From time to time, the Group elects to renegotiate the terms of trade receivables due from customers with which it has previously had a good trading history. Such renegotiations will lead to changes in the timing of payments rather than changes to the amounts owed and, in consequence, the new expected cash flows are discounted at the original effective interest rate.

The Group's loans and receivables comprise trade and other receivables and cash and cash equivalents in the balance sheet.


 Available-for-sale:  Non-derivative financial assets not included in the above categories are classified as available-for-sale and comprise principally the Group's strategic investments in entities not qualifying as subsidiaries, associates or jointly controlled entities as well as corporate bonds. They are carried at fair value with changes in fair value recognised directly in a separate component of equity (available-for-sale reserve) other than exchange differences on corporate bonds denominated in foreign currency, which are recognised in profit or loss. Where there is a significant or prolonged decline in the fair value of an available for sale financial asset (which constitutes objective evidence of impairment), the full amount of the impairment, including any amount previously charged to equity, is recognised in the income statement.  Purchases and sales of available for sale financial assets are recognised on settlement date with any change in fair value between trade date and settlement date being recognised in the available for sale reserve. On sale, the amount held in the available for sale reserve associated with that asset is removed from equity and recognised in the income statement. Interest on corporate bonds classified as available for sale is calculated using the effective interest method and is recognised in finance income in the income statement.


    

               Financial liabilities


The Group classifies its financial liabilities into one of two categories, depending on the purpose for which the liability was acquired.  


The Group's accounting policy for each category is as follows:


Fair value through profit or loss:  The Group does not have any liabilities held for trading nor has it designated any financial liabilities as being at fair value through profit or loss.


Other financial liabilities:  Other financial liabilities include the following items:


Bank borrowings are initially recognised at fair value net of any transaction costs directly attributable to the issue of the instrument. Such interest bearing liabilities are subsequently measured at amortised cost using the effective interest rate method, which ensures that any interest expense over the period to repayment is at a constant rate on the balance of the liability carried in the balance sheet. Interest expense in this context includes initial transaction costs and premia payable on redemption, as well as any interest or coupon payable while the liability is outstanding.

Trade payables and other short-term monetary liabilities are initially recognised at fair value and subsequently carried at amortised cost using the effective interest method.



Pledged assets


The Group may enter into stock borrowing arrangements with certain institutions which are entered into on a collateralised basis with securities or cash advances received as collateral.

Under such arrangements a security is purchased with a commitment to return it at a future date at a future agreed price.  The securities purchased are not recognised on the balance sheet and the transaction is treated as a secured loan made for the purchase price.

Where cash has been used to effect the purchase, the cash collateral amount is recorded as a pledged asset on the balance sheet.



2)           Revenue



Six months

ended

30 April 2008

Unaudited

Six months

ended

30 April 2007

Unaudited

Year 

ended

31 October 2007

Unaudited


£'000

£'000

£'000

Equities Division

4,138

3,537

7,444

Corporate Finance division

2,519

4,911

9,375

Total revenue

6,657

8,448

16,819


    The Directors are of the opinion that there are only two business segments and disclose only in terms of turnover the reporting segments of the Group.


3)        Administrative expenses



Six months

ended

30 April 2008

Unaudited

Six months

ended

30 April 2007

Unaudited 

Year 
ended

31 October 2007 
Unaudited


£'000

£'000

£'000

Staff costs

3,255

3,662

7,120

Overheads

2,336

1,971

4,633

Staff and overhead costs

5,591

5,633

11,753

Exceptional items

-

318

318

Total administrative costs

5,591

5,951

12,071


    Note: staff costs include a charge of £275,000 (Interim 2007£17,000, Final 2007: £34,000) for share based payments (IFRS 2).



4)      Earnings per share


      Basic earnings per share is calculated on profit after tax of £819,000 (2007: £1,818,000) and 24,701,872 (2007: 24,701,872) being the 
     weighted average number of ordinary shares in issue during the period.


    Diluted earnings per share takes account of the weighted average number of outstanding share options 
    being 
1,245,685 (20071,077,998).


    Underlying basic earnings per share of 4.4p (20078.8p) and the underlying diluted earnings per share of 4.2p (2007: 8.4p) for the six 
   months ended 30 April 200
8 is calculated on profit after tax of £1,094,000 (2007: £2,170,000) being the profit after tax, adjusted for the 
   post tax impact of 
IFRS 2 costs of £275,000 (2007: £34,000) and exceptional costs of £Nil (2007: £318,000).


5)      Dividends



Six months

ended

30 April 2008

Unaudited

Six months

ended

30 April 2007

Unaudited 

Year 

ended

31 October 2007

Unaudited


£'000

£'000

£'000

Final dividend year ended 31 October 2007

1,081

445

445

Interim dividend year ended 31 October 2007

-

-

400

Distribution to equity shareholders

1,081

445

845


The Board has declared an interim dividend of 2.2p (2007: 2.2p). The dividend will be payable on 3 October 2008 to all shareholders on the register at 12 September 2008.  The interim dividend has not been accrued in these financial statements.



6)    Transition to IFRS 


The financial information for the six months ended 30 April 2007, the year ended 31 October 2007 and the opening balance sheet at 1 November 2006 have been prepared in accordance with International Financial Reporting Standards (IFRS) for the first time.


The Group's transition date to IFRS is 1 November 2006. The rules for first-time adoption of IFRS are set out in IFRS 1 'First time adoption of international financial reporting standards'. In preparing the IFRS financial information, these transition rules have been applied to the amounts reported previously under generally accepted accounting principles in the United Kingdom ('UK GAAP').  IFRS 1 generally requires full retrospective application of the Standards and Interpretations in force at the first reporting date. However, IFRS 1 allows certain exemptions in the application of particular Standards to prior periods in order to assist companies with the transition process.


The Group has elected to make use of the exemptions available in IFRS 1 as follows:


IFRS 2 'Share-based Payments' has been applied to all grants of equity instruments after 7 November 2002 that were unvested at 1 November 2006.


IFRS 3 'Business Combinations' has not been applied retrospectively to business combinations that occurred before 1 November 2006.


  7)        Reconciliation of UK GAAP to IFRS:


For the period ended 30 April 2007 and the year ended 31 October 2007 there are differences between the income statement and balance sheet amounts reported under UK GAAP and IFRS as noted on the following pages. There are also differences under UK GAAP and IFRS for the opening balance sheet on transition (as at 1 November 2006). 


There is no monetary impact on the cash flow statement following the adoption of IFRS for these above periods.


The IFRS transition has given rise to three types of adjustments, these are as follows:


a)    Fair value adjustments for financial assets that are classed as held for trading, with movements in the fair value going to the income statement;


b    Fair value adjustments for financial assets that are classified as available for sale with movements in the fair value going through equity;


c)    Tax relating to the above.



8)        Risks


 The principal financial and non-financial risks facing the group are disclosed within note 28 of the Annual Report for the year ended 31 October 2007, a copy of which is available at the Group's website (www.arden-partners.com).




  

Statement of Directors' Responsibilities


The Directors confirm that this condensed set of financial statements has been prepared in accordance with IAS 34 as adopted by the European Union, and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8.


The Directors of Arden Partners plc are listed in the Annual Report for the year ended 31 October 2007.


A list of the current Directors is maintained on the Arden Partners website (www.arden-partners.com).


By Order of the Board


Jonathan Keeling

Chief Executive


Trevor Norris

Finance Director


31 July 2008









Re-statement of Historical Financial Information Under IFRS

Consolidated financial information for the six months ended 30 April 2007


 
 
UK GAAP
At
30 April 2007
(Unaudited)
IFRS Adjustments
IFRS
At
30 April 2007
(Unaudited)
 
 
£’000
£’000
£’000
Assets
 
 
 
 
Non-current assets
 
 
 
 
Plant property and equipment
 
443
-
443
Deferred Tax
 
-
5
5
Total non-current assets
 
443
5
448
Current assets
 
 
 
 
Financial assets – held for trading
 
2,802
4
2,806
Financial assets- available for sale
 
853
(31)
822
Pledged assets
 
882
-
882
Trade and other receivables
 
13,155
-
13,155
Cash and cash equivalents
 
5,289
-
5,289
Total current assets
 
22,981
(27)
22,954
Total assets
 
23,424
(22)
23,402
 
Current liabilities
 
 
 
 
Trade and other payables
 
13,401
-
13,401
Corporation tax liability
 
851
-
851
Total current liabilities
 
14,252
-
14,252
 
Non current liabilities
 
 
 
 
Deferred tax liability
 
-
-
-
Total non-current liabilities
 
-
-
-
Total liabilities
 
14,252
-
14,252
Net assets
 
9,172
(22)
9,150

 




Consolidated financial information for the six months ended 30 April 2007

                                    



UK GAAP

Six months

Ended

30 April 2007

(Unaudited) 

IFRS

adjustments

IFRS

Six months

Ended

30 April 2007

(Unaudited)



£'000

£'000

£'000






Revenue


8,434

14

8,448

Administrative expenses 


5,951

-

5,951

Profit from operations


2,483

14

2,497

Finance income 


184

-

184

Finance costs


6

-

6

Profit before taxation


2,661

14

2,675

Income tax expense


850

7

857

Profit on ordinary activities after taxation


1,811

7

1,818






Earnings per share





Basic


7.3p


7.4p

Diluted


7.0p


7.1p

                



   

Consolidated financial information for the year ended 31 October 2007




UK GAAP

At

31 October 2007

(Audited)


IFRS

adjustments



IFRS

At

31 October 2007

(Unaudited)




£'000

£'000

£'000

Assets





Non -current assets





Plant property and equipment


512

-

512

Total non-current assets


512

-

512

Current assets





Financial assets - held for trading


1,617

35

1,652

Financial assets- available for sale


392

51

443

Trade and other receivables


9,753

-

9,753

Cash at bank and in hand


7,855

-

7,855

Total current assets


19,617

86 

19,703

Total assets


20,129

86

20,215

Current liabilities





Trade and other payables


8,992

-

8,992

                

Corporation tax liability


806

-

806

Total current liabilities


9,798

-

9,798

Non current liabilities





Deferred tax liability 


-

28

28

Total non-current liabilities


-

28

28

Total liabilities


9,798

28

9,826

Net assets 


10,331

58

10,389

                                    



  

Consolidated financial information for the year ended 31 October 2007





UK GAAP

Year ended

31 October 2007

(Audited)

IFRS

adjustments


IFRS

Year ended

31 October 2007

(Unaudited)



£'000

£'000

£'000

Revenue


16,774

45

16,819

Administrative expenses 


12,071

-

12,071

Profit from operations


4,703

45

4,748

Finance income 


461

-

461

Finance costs


3

-

3

Profit before taxation


5,161

45

5,206

Income tax expense


1,704

13

1,717 

Profit on ordinary activities after taxation


3,457

32

3,489



    


    

Earnings per share





Basic


14.0p


14.1p

Diluted


13.0p


13.1p

                                    


  

Consolidated balance sheet as at 1 November 2006


 
 
 
UK GAAP
At
31 October 2006
(Audited)
IFRS
adjustments
 
IFRS
At
1 November 2006
(Unaudited)
 
 
£’000
£’000
£’000
Assets
 
 
 
 
Non-current assets
 
 
 
 
Plant property and equipment
 
388
-
388
Deferred Tax
 
-
48
48
Total non-current assets
 
388
48
436
 
 
 
 
 
Current assets
 
 
 
 
Financial assets – held for trading
 
1,217
(10)
1,207
Financial assets- available for sale
 
583
(152)
431
Trade and other receivables
 
7,169
-
7,169
Cash and cash equivalents
 
8,260
-
8,260
Total current assets
 
17,229
(162)
17,067
Total assets
 
17,617
(114)
17,503
Current liabilities
 
 
 
 
Trade and other payables
 
9,151
-
9,151
Corporation tax liability
 
677
-
677
Total current liabilities
 
9,828
-
9,828
Total liabilities
 
9,828
-
9,828
Net assets
 
7,789
(114)
7,675


 


Independent Review Report

Introduction


We have been engaged by the Group to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 April 2008 which comprises the Consolidated Income Statement, the Consolidated Statement of Changes in Equity, the Consolidated Balance Sheet, the Consolidated Cash flow statement and related notes.


We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.


Directors' responsibilities


The half-yearly financial report is the responsibility of and has been approved by the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.


As disclosed in note 1 the annual financial statements of the group are prepared in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, ''Interim Financial Reporting'', as adopted by the European Union.


Our responsibility


Our responsibility is to express to the Group a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.


Our report has been prepared in accordance with the terms of our engagement to assist the Group in meeting its responsibilities in respect to half-yearly financial reporting in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority and for no other purpose. No person is entitled to rely on this report unless such a person is a person entitled to rely upon this report by virtue of and for the purpose of our terms of engagement or has been expressly authorised to do so by our prior written consent. Save as above, we do not accept responsibility for this report to any other person or for any other purpose and we hereby expressly disclaim any and all such liability.


Scope of review


We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, ''Review of Interim Financial Information Performed by the Independent Auditor of the Entity'', issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.


Conclusion


Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 April 2008 is not prepared, in all material respects, in accordance with International Accounting Standard 34, as adopted by the European Union, and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.


BDO Stoy Hayward LLP

Chartered Accountants and Registered Auditors

London

31 July 2008




Directors

Sir David Rowe-Ham - Chairman

Jonathan Keeling -  Chief Executive Officer

Trevor Norris - Group Finance Director

Tony Bartlett - Non Executive Director

Philip Dayer - Non Executive Director

Grahame Whateley - Non Executive Director


Company Secretary and Registered Office


Trevor Norris

Arden House

Highfield Road

Edgbaston

Birmingham

B15 3JU 


Direct line : 0121 423 8990

Fax : 0121 423 8991

Company Number

4427253

Company Web Address

www.arden-partners.co.uk


Nominated Advisor and Broker


Altium Securities Limited

30 St James's Square
London
SW1Y 4AL


Financial PR 


Buchanan Communications

45 Moorfields

London

EC2Y 9AE


Registrar


Capita IRG Plc

The Registry
34 Beckenham Road
Beckenham
Kent 

BR3 4TU


Lawyers


Eversheds LLP

115 Colmore Row

Birmingham  

B3 3AL


Auditors

BDO Stoy Hayward LLP

55 Baker Street

London

W1U 7EU


Bankers

RBS

8th Floor

280 Bishopsgate

London  

EC2M 4RB



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SDLSAFSASEFW